Inventor · disambiguated record
Klaus Ley
Also filed as: LEY KLAUS · LEY KLAUS F
3 granted patents·12 pending applications·9 citations·filing 2003–2021
58Inventor score
Files withLA JOLLA INST ALLERGY & IMMUNOLOGY4JOLLA INST ALLERGY IMMUNOLOG3UNIV VIRGINIA3KASSAB GHASSAN S1KLIBANOV ALEXANDER L1
Top patents by PatentIndex Score
15 records- 0168US12448433B2Human ApoB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2021·Granted Oct 21, 2025·0 cites·13 claims
- 0268US7462489B2Methods for identifying and analyzing biomarkers from plasma-derived microparticlesLEY KLAUS F·Filed 2007·Granted Dec 9, 2008·9 cites·20 claims
- 0348US11130798B2Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosisLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2016·Granted Sep 28, 2021·0 cites·20 claims
- 0445US2020060662A1Methods and devices for gaseous sample collection and storageKASSAB GHASSAN S·Filed 2019·Application pending·0 cites
- 0543US2015119333A1Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)JOLLA INST ALLERGY IMMUNOLOG·Filed 2013·Application pending·0 cites
- 0643US2005260189A1Microbubble compositions, and methods for preparing and using sameKLIBANOV ALEXANDER L·Filed 2003·Application pending·0 cites
- 0742US2009093005A1Protein-based biomarkers for abdominal aortic aneurysmUNIV VIRGINIA·Filed 2008·Application pending·0 cites
- 0841US2012121590A1Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)LEY KLAUS·Filed 2010·Application pending·0 cites
- 0940US2009022712A1Compositions and Methods for Inhibiting Leukocyte FunctionUNIV VIRGINIA·Filed 2007·Application pending·0 cites
- 1040US2023204579A1Immune Cell Biomarkers of Cardiovascular DiseaseLA JOLLA INST FOR IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 1138US2010055723A1Galectin-3-Binding Protein as a Biomarker of Cardiovascular DiseaseUNIV VIRGINIA·Filed 2008·Application pending·0 cites
- 1238US2021145768A1Modulating immune response via targeting of olfactory receptor activityLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 1337US2013108602A1Methods and uses of nur77 and nur77 agonists to modulate macrophages and monocytes, and treat inflammation, inflammatory disease and cardiovascular diseaseJOLLA INST ALLERGY IMMUNOLOG·Filed 2012·Application pending·0 cites
- 1437US2018369330A1Methods and compositions using integrin-based therapeuticsLA JOLLA INST ALLERGY & IMMUNOLOGY·Filed 2017·Application pending·0 cites
- 1533US2013095127A1METHODS OF INHIBITING INFLAMMATION AND INFLAMMATORY DISEASES USING Gal-3BP (BTBD17B, LGALS3BP, GALECTIN-3 BINDING PROTEIN, MAC-2 BINDING PROTEIN)JOLLA INST ALLERGY IMMUNOLOG·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus Ley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →